Alexandre G. Vouga

Alexandre G. Vouga

Auto-generated profile, based on publicly available information

Alexandre G. Vouga

Department of Medical Genetics and Molecular Biochemistry, Temple University Lewis Katz School of Medicine, Philadelphia, PA 1

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
MRMichael E. Rockman
Michael E. Rockman
AVAlexandre G. Vouga
Alexandre G. Vouga
BRBrad S. Rothberg
Brad S. Rothberg
Large-conductance Ca2+-activated K+ channels (BK channels) are activated by cytosolic calcium and depolarized membrane potential under physiological conditions. Thus, these channels control electrical excitability in neurons and smooth muscle by gating K+ efflux and hyperpolarizing the membrane in response to Ca2+ signaling. Altered BK channel function has been linked to epilepsy, dyskinesia, and other neurological deficits in humans, making these channels a key target for drug therapies. To gain insight into mechanisms underlying pharmacological modulation of BK channel gating, here we studied mechanisms underlying activation of BK channels by the biarylthiourea derivative, NS11021, which acts as a smooth muscle relaxant. We observe that increasing NS11021 shifts the half-maximal activation voltage for BK channels toward more hyperpolarized voltages, in both the presence and nominal absence of Ca2+, suggesting that NS11021 facilitates BK channel activation primarily by a mechanism that is distinct from Ca2+ activation. 30 µM NS11021 slows the time course of BK channel deactivation at −200 mV by ∼10-fold compared with 0 µM NS11021, while having little effect on the time course of activation. This action is most pronounced at negative voltages, at which the BK channel voltage sensors are at rest. Single-channel kinetic analysis further shows that 30 µM NS11021 increases open probability by 62-fold and increases mean open time from 0.15 to 0.52 ms in the nominal absence of Ca2+ at voltages less than −60 mV, conditions in which BK voltage sensors are largely in the resting state. We could therefore account for the major activating effects of NS11021 by a scheme in which the drug primarily shifts the pore-gate equilibrium toward the open state.

6 August 2021 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
AVAlexandre G. Vouga
Alexandre G. Vouga
MRMichael E. Rockman
Michael E. Rockman
JYJiusheng Yan
Jiusheng Yan
MJMarlene A. Jacobson
Marlene A. Jacobson
BRBrad S. Rothberg
Brad S. Rothberg
Large-conductance Ca2+-activated K+ (BK) channels control a range of physiological functions, and their dysfunction is linked to human disease. We have found that the widely used drug loperamide (LOP) can inhibit activity of BK channels composed of either α-subunits (BKα channels) or α-subunits plus the auxiliary γ1-subunit (BKα/γ1 channels), and here we analyze the molecular mechanism of LOP action. LOP applied at the cytosolic side of the membrane rapidly and reversibly inhibited BK current, an effect that appeared as a decay in voltage-activated BK currents. The apparent affinity for LOP decreased with hyperpolarization in a manner consistent with LOP behaving as an inhibitor of open, activated channels. Increasing LOP concentration reduced the half-maximal activation voltage, consistent with relative stabilization of the LOP-inhibited open state. Single-channel recordings revealed that LOP did not reduce unitary BK channel current, but instead decreased BK channel open probability and mean open times. LOP elicited use-dependent inhibition, in which trains of brief depolarizing steps lead to accumulated reduction of BK current, whereas single brief depolarizing steps do not. The principal effects of LOP on BK channel gating are described by a mechanism in which LOP acts as a state-dependent pore blocker. Our results suggest that therapeutic doses of LOP may act in part by inhibiting K+ efflux through intestinal BK channels.

1 February 2016 in Biophysical Journal
Verified
Journal Article
Open access
PDF file
AVAlexandre G. Vouga
Alexandre G. Vouga
EHEunan Hendron
Eunan Hendron
BRBrad S. Rothberg
Brad S. Rothberg
Cytoplasmic gating ring (CORE-MT) could be activated by voltage. In this study, we measured the voltage sensor activation (gating currents) and pore opening (ionic currents) of this CORE-MT channel at various voltages. We found that voltage sensor activation in this truncated channel is similar as in the WT BK channel with a similar number of total gating charges and a small ~20mV leftward shift for the charge-voltage (Qon-V) relation. However, the coupling between voltage sensor activation and the activation gate was reduced as indicated by a rightward shift in the (G/GMax-V) relation. These results suggest that the gating ring, in addition to its requirement for Ca 2þ dependent activation, also enhances the effective coupling between voltage sensors and the activation gate. We also found that the removal of the gating ring alters modulation of the channels by b1 and b2 subunits of BK channels.